Velicept nets $21M for overactive bladder drug
Velicept's overactive bladder drug, solabegron, was developed initially by GlaxoSmithKline for IBS as well - but was acquired in 2011.
velicept therapuetics
Velicept's overactive bladder drug, solabegron, was developed initially by GlaxoSmithKline for IBS as well - but was acquired in 2011.